2 weeks Ago By ABMN Staff
Canada Goose Holdings Inc. ( NYSE:GOOS – Get Free Report )’s stock price shot up 4.9% on Friday .
The stock traded as high as $12.45 and last traded at $12.44.
131,558 shares traded hands during trading, a decline of 86% from the average session volume of 929,160 shares. The stock had previously closed at $11.86.
Wall Street Analyst Weigh In GOOS has been the topic of a number of research reports. UBS Group cut their price objective on Canada Goose from $14.00 to $13.
00 and set a “neutral” rating on the stock in a report on Friday, August 2nd. Raymond James cut Canada Goose from an “outperform” rating to a “market perform” rating in a report on Tuesday, July 23rd. Wedbush started coverage on Canada Goose in a report on Friday, July 19th.
They set an “outperform” rating on the stock. Finally, Barclays decreased their price objective on shares of Canada Goose from $13.00 to $12.
00 and set an “equal weight” rating for the company in a research report on Friday, August 2nd. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.
com, the company presently has a consensus rating of “Hold” and a consensus target price of $14.07. Check Out Our Latest Analysis on Canada Goose Canada Goose Price Performance Canada Goose ( NYSE:GOOS – Get Free Report ) last released its quarterly earnings results on Thursday, August 1st.
The company reported ($0.58) earnings per share for the quarter, topping the consensus estimate of ($0.60) by $0.
02. Canada Goose had a net margin of 4.66% and a return on equity of 25.
63%. The firm had revenue of $64.39 million during the quarter, compared to the consensus estimate of $63.
47 million. Equities research analysts predict that Canada Goose Holdings Inc. will post 0.
83 earnings per share for the current year. Institutional Trading of Canada Goose Institutional investors have recently made changes to their positions in the company. Patient Capital Management LLC raised its stake in Canada Goose by 16.
0% in the 4th quarter. Patient Capital Management LLC now owns 3,842,824 shares of the company’s stock valued at $45,537,000 after purchasing an additional 529,177 shares during the last quarter. Marshall Wace LLP raised its position in shares of Canada Goose by 8.
1% in the second quarter. Marshall Wace LLP now owns 1,087,414 shares of the company’s stock valued at $14,060,000 after buying an additional 81,090 shares during the last quarter. Pinnacle Associates Ltd.
lifted its stake in shares of Canada Goose by 1.2% in the first quarter. Pinnacle Associates Ltd.
now owns 609,408 shares of the company’s stock worth $7,349,000 after buying an additional 7,067 shares in the last quarter. Silvercrest Asset Management Group LLC boosted its position in Canada Goose by 0.5% during the first quarter.
Silvercrest Asset Management Group LLC now owns 605,050 shares of the company’s stock worth $7,297,000 after acquiring an additional 2,752 shares during the last quarter. Finally, Armistice Capital LLC purchased a new stake in Canada Goose during the 2nd quarter valued at about $4,332,000. 83.
64% of the stock is owned by institutional investors and hedge funds. About Canada Goose ( Get Free Report ) Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.
See Also Receive News & Ratings for Canada Goose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canada Goose and related companies with MarketBeat.com's FREE daily email newsletter ..
